ARTICLE | Clinical News
Hematopoietic stem cells: Phase I suspended enrollment
September 26, 2005 7:00 AM UTC
VIAC suspended enrollment in a Phase I trial of CB001 for use in hematopoietic stem cell transplantation to treat cancer. The trial was stopped after 2 cases of grade IV acute graft-versus-host-diseas...